Dr. Luis E. Fayad, MD

  • Houston, TX
  • Hematologist and oncologist
NPI1205921095PAC ID4981897006
Medicare services, 2024
894
Medicare patients, 2024
280
Part D claims, 2024
350
Publications
219
Clinical trials
5
Practice address
1515 Holcombe Blvd, Houston, TX 77030
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Find Dr. Fayad's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Luis E. Fayad is a hematologist and oncologist in Houston, Texas

Dr. Fayad practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Fayad's NPI, 1205921095, was assigned on October 4, 2006. Dr. Fayad graduated from Universidad Catolica de Santiago de Guayaquil in 1985. Dr. Fayad holds Texas license J7482.

NPI and contact details
Medicare PAC ID
4981897006
NPI enumeration date
October 4, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
67
Medical school graduation
1985

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Luis E. Fayad practices at The University of Texas MD Anderson Cancer Center in Houston, Texas

Dr. Fayad's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Source: Dmand AI Affiliation Data

Dr. Luis E. Fayad is affiliated with 1 site of care and 1 medical group

Dr. Fayad's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Luis E. Fayad's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fayad practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
The University of Texas MD Anderson Cancer CenterAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Fayad practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Luis E. Fayad is one of 814 hematologists and oncologists in Texas

Hematology and oncology is Dr. Fayad's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Fayad's licenses on file in 5 states: Texas, Florida, Oklahoma, Arizona and Nevada.

Specialties and state licenses

  • Hematology and oncology, TexasPrimaryLicense J7482 · 1995 to 2026 · taxonomy 207RH0003X
  • Florida licenseSince 2021
  • Oklahoma license2020 to 2021
  • Arizona license1999 to 2014
  • Nevada license1997 to 2011

Clinical focus

Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease, lymphoma and multiple myeloma among the conditions Dr. Fayad treats.

Hematologists and oncologists near Dr. Fayad

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Luis E. Fayad billed Medicare for 894 services in 2024

CMS data shows 894 Medicare services from Dr. Fayad across 9 procedure codes in 2024, for 280 Medicare patients. Medicare paid $74,907 for them.

Medicare services, 2024894
Medicare patients280
Paid by Medicare$74,907
Procedure codes9

Dr. Fayad's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 8922024: 894No change

Where Dr. Fayad's Medicare services took place, 2024

  • In an office556%
  • In a facility83994%

Dr. Fayad compared with the Texas median for hematologists and oncologists, 2024

  • Dr. Fayad
  • Texas median
Medicare services
894vs 1,16223% below
Medicare patients
280vs 25112% above
Part D claims
179vs 48963% below

Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.

Dr. Fayad's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Fayad

Need commercial claims for Dr. Fayad?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Fayad and other hematologists and oncologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Luis E. Fayad treated 280 Medicare patients in 2024, average age 72

CMS counts 280 Medicare patients who saw Dr. Fayad in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fayad's median patient age at 72, with 40% women.

Medicare patients, 2024280
Average age72
Average risk score2.47
Also on Medicaid4%

Dr. Fayad's Medicare patients by age, 2024

Dr. Fayad's Medicare patients by sex, 2024

  • Women10939%
  • Men17161%

Chronic conditions among Dr. Fayad's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis52%
  4. Diabetes37%
  5. Ischemic heart disease36%
  6. Anxiety34%
  7. Chronic kidney disease33%
  8. Mood disorders31%

Share of Medicare patients with each condition. A patient can have several.

Dr. Fayad's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women40%
  • Men60%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Luis E. Fayad wrote 350 Medicare Part D claims in 2024

In 2024, Dr. Fayad wrote 350 Medicare Part D claims for 96 patients. 86% of them were for generic drugs. CMS names the drug for 179 of them, across 8 drugs with 11 or more claims each, at $432,280 in total drug cost. In 2023, CMS named 127 claims across 6 drugs.

Part D claims, 2024350
Drugs named by CMS8
Total drug cost$432,280
Part D patients96

Dr. Fayad's Part D claims by kind of drug, 2024

  • Generic300 claims86%
  • Brand-name and other50 claims14%

Dr. Fayad's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Fayad's Part D claims, 2024

  • Antibiotics14%48 of 350 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1272024: 17941%

Drugs named by CMS: 8 in 2024, 6 in 2023.

See all prescribing by Dr. Fayad

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Luis E. Fayad scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Fayad for performance year 2024, reported as part of a group. Dr. Fayad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fayad as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Fayad's MIPS scores, performance year 2024

  • 84of 100Final score
  • 70.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 68of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Fayad by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Luis E. Fayad has 219 publications on record

Dmand AI links 219 papers to Dr. Fayad, published from 2004 to 2025. 2020 was the busiest year, with 17. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Rituximab and Lymphoma, Large B-Cell, Diffuse. Dr. Fayad has published most often in Leuk Lymphoma. Dr. Fayad's most frequent co-authors are Sattva S. Neelapu, MD, Fredrick B. Hagemeister, MD and Jason R. Westin, MD.

Papers219
Years published2004 to 2025

Dr. Fayad's papers by year, 2016 to 2025

Topics Dr. Fayad writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Rituximab
  • Lymphoma, Large B-Cell, Diffuse
  • Doxorubicin
  • Cyclophosphamide
  • Vincristine
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents

Dr. Fayad's most frequent co-authors

Recent publications by Dr. Fayad

See all 219 publications and co-authors

See who Dr. Fayad researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Fayad works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Luis E. Fayad has worked on 5 clinical trials

Dmand AI links Dr. Fayad to 5 clinical trials, 4 of them phase 2 studies. Conditions studied include Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse and Lymphoma, Non-Hodgkin. M.D. Anderson Cancer Center sponsors the most, 2.

Clinical trials with Dr. Fayad by phase

  1. 1Phase 1: 1 trial
  2. 4Phase 2: 4 trials
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. Fayad's trials

  • Lymphoma, B-Cell
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
  • Lymphoma, Large-Cell, Immunoblastic
  • Lymphoma, Mantle-Cell

Investigators on the most trials with Dr. Fayad

Recent clinical trials with Dr. Fayad

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Luis E. Fayad received $22,047 in industry payments from 2016 to 2025

CMS Open Payments shows 50 general payments to Dr. Fayad from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 28% of the total. Amgen Inc. paid the most, $12,848. It also lists 2 research payments totaling $1,233 in 2024.

General payments to Dr. Fayad by program year, 2016 to 2025

General payments to Dr. Fayad by kind, 2016 to 2025

$22Kin total
  • Speaker and faculty fees$6,16028%
  • Consulting fees$5,61325%
  • Food and beverage$4,63621%
  • Honoraria$3,00014%
  • Other$2,63812%

Companies that paid Dr. Fayad the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Fayad

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Luis E. Fayad has 1 award and honors on record

Dmand AI lists 1 award for Dr. Fayad, most recently Regional Top Doctor in 2014.

Awards and honors for Dr. Fayad

  1. 2014
    • Regional Top Doctor

Source: Dmand AI Professional Profile Data

Dr. Luis E. Fayad graduated from Universidad Catolica de Santiago de Guayaquil

Dr. Fayad graduated from Universidad Catolica de Santiago de Guayaquil in 1985.

  1. Medical schoolUniversidad Catolica de Santiago de Guayaquil

Source: Dmand AI Professional Profile Data

Dr. Luis E. Fayad accepts plans from 14 insurance carriers

Dr. Fayad is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.

  • Aetna
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Alliant Health Plans
  • Elevance
  • HCSC
  • Baylor Scott and White
  • Blue Cross and Blue Shield of Kansas City
  • +6 more carriersWith a free account

Plan types Dr. Fayad accepts, by number of carriers

  1. HMO9
  2. PPO8
  3. POS4
  4. Medicare3
  5. EPO2

Source: Dmand AI Insurance Network Data

Sources for Dr. Luis E. Fayad's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Luis E. Fayad

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Luis E. Fayad's NPI number?

Dr. Luis E. Fayad's NPI number is 1205921095. It was assigned on October 4, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Luis E. Fayad?

Dr. Luis E. Fayad is a hematologist and oncologist in Houston, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Luis E. Fayad practice?

Dr. Fayad practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Fayad's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

What is Dr. Luis E. Fayad's medical license number?

Dr. Fayad holds Texas license J7482, one of the licenses on file in 5 states.

Which states has Dr. Luis E. Fayad been licensed in?

Dmand AI has state licenses on file for Dr. Fayad in Texas (1995 to 2026), Florida (since 2021), Oklahoma (2020 to 2021), Arizona (1999 to 2014) and Nevada (1997 to 2011).

Which hospitals is Dr. Luis E. Fayad affiliated with?

Dr. Fayad practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.

What medical group is Dr. Luis E. Fayad part of?

Dr. Fayad is linked to Physicians Referral Service.

Does Dr. Luis E. Fayad accept Medicare?

Yes. CMS data shows Dr. Fayad billed Medicare for 894 services in 2024, and Dr. Fayad accepts Medicare assignment.

Does Dr. Luis E. Fayad offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Fayad as offering telehealth services.

What is Dr. Luis E. Fayad's MIPS score?

Dr. Fayad's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

Show 9 more questionsShow fewer questions

How many Medicare patients does Dr. Luis E. Fayad see?

CMS counts 280 Medicare patients who saw Dr. Fayad in 2024, with an average age of 72.

What services does Dr. Luis E. Fayad bill to Medicare?

In 2024, Dr. Fayad's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and hospital inpatient care (99232).

Where did Dr. Luis E. Fayad go to medical school?

Dr. Fayad graduated from Universidad Catolica de Santiago de Guayaquil in 1985.

What drugs does Dr. Luis E. Fayad prescribe most?

In 2024 Medicare Part D data, Dr. Fayad's most prescribed drugs by claims were Valacyclovir, Pantoprazole Sodium and Revlimid.

Has Dr. Luis E. Fayad received payments from drug or device companies?

CMS Open Payments shows $22,047 in general payments to Dr. Fayad from 18 companies from 2016 to 2025. The largest total came from Amgen Inc.

How long has Dr. Luis E. Fayad been practicing?

Dr. Fayad graduated from medical school in 1985, 41 years ago.

Does Dr. Luis E. Fayad do research?

Dmand AI links 219 publications to Dr. Fayad, published from 2004 to 2025. Dr. Fayad has worked on 5 clinical trials.

Who does Dr. Luis E. Fayad publish with?

Dr. Fayad's most frequent co-authors are Sattva S. Neelapu, MD (84 shared papers), Fredrick B. Hagemeister, MD (72 shared papers) and Jason R. Westin, MD (70 shared papers).

What insurance does Dr. Luis E. Fayad accept?

Dr. Fayad is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)